Zepbound Cost: Every Price Path Compared (2026)

How much does Zepbound cost, once you count every path?

There isn't one Zepbound price. There are eight ways to pay, and they barely overlap. Where you land depends mostly on one question: does your plan cover Zepbound for you?

• Insured, Zepbound covered, savings card used. As little as $25 a month. This is the best case.
• On Medicare drug coverage, called Part D. $50 a month for the Zepbound KwikPen through the GLP-1 Bridge, if you qualify.
• No insurance, Lilly self-pay. About $300 to $450 a month by dose, from Lilly or a local pharmacy.
• Insured, but your plan excludes Zepbound. About $500 a month for the single-dose pen with the savings card. Lilly's self-pay KwikPen costs less.
• Through a telehealth service like LifeMD. Lilly's self-pay price plus a monthly membership.
• Retail pharmacy with a coupon. About $995 to $1,050 a month, barely below list price.
• List price, no program. About $1,085 a month. Almost no one should pay this.
• Compounded tirzepatide. About $130 to $650 a month. It's a related but different product, not Zepbound.

The rest of this page walks through each path. It also covers the two questions that trip people up most: what insurance will pay, and whether a cheaper compounded price buys the same drug.

What does Lilly's self-pay Zepbound cost, dose by dose?

LillyDirect is Eli Lilly's own pharmacy service, not a discounter. Paying cash, brand-name Zepbound costs more as your dose goes up:

• 2.5 mg, the starting dose: about $300 a month.
• 5 mg: about $400 a month.
• 7.5 mg to 15 mg: about $450 a month, if you refill within 45 days.

The single-dose vial and the KwikPen, a pen that holds a month of doses, share these prices. Since March 16, 2026, you can also buy the KwikPen at this price at many local pharmacies. Vials are sold only through LillyDirect.

Build one habit around the higher doses. To keep that price, refill within 45 days of your last delivery. Miss that window and a 7.5 mg fill costs about $500. From 10 mg, a late fill costs about $700.

Two more limits apply. Lilly's KwikPen self-pay terms cover up to 11 fills in a calendar year. These terms, like the savings card, end December 31, 2026. LillyDirect Zepbound pricing explains how to order, and Zepbound without insurance covers the vial-versus-pen choice.

Does insurance cover Zepbound, and what's the copay with the savings card?

Zepbound is FDA-approved for three situations. The first is obesity. The second is being overweight with a weight-related condition, like high blood pressure. The third is moderate to severe sleep apnea with obesity.

Whether your plan pays is a separate question. Coverage for weight-loss drugs varies widely by employer and plan. Most plans check for a qualifying diagnosis from your prescriber. That is often a prior authorization, a form your insurer must approve first. Lilly says some CVS Caremark plans have put Zepbound back on their drug lists. Zepbound insurance explains how to check and appeal.

If your plan covers it, Lilly's savings card can bring a fill down to as little as $25. A $25 fill can cover one, two or three months. The card pays up to $100 a month. It stops at $1,300 a year, which people with a high deductible can reach early in the year.

The card works only with commercial insurance, the kind you get through work or buy yourself. Its current terms end December 31, 2026. Zepbound savings card walks through signing up.

If your commercial plan excludes Zepbound, the card brings the single-dose pen to about $500 a month. Lilly's self-pay KwikPen is cheaper at every dose, so compare before you fill.

What if you have Medicare?

Medicare has long been barred from paying for weight-loss drugs. That changed in part on July 1, 2026, when the Medicare GLP-1 Bridge began. Through December 31, 2027, people with Part D who meet its rules pay $50 a month for the Zepbound KwikPen.

The rules include BMI limits and qualifying conditions. People with type 2 diabetes, moderate to severe sleep apnea or fatty liver disease can't use the Bridge. Their own Part D plan may still cover a GLP-1 for those conditions. Extra Help, Medicare's low-income drug aid, doesn't lower the $50.

Wegovy and Foundayo are also covered. The single-dose Zepbound pen and vials are not.

What does Zepbound cost through LifeMD?

LifeMD is a publicly traded telehealth company. It prescribes Zepbound as a KwikPen, vial or single-dose pen, but it doesn't set the drug's price. You pay in two pieces that are easy to mix up.

• The membership. About $150 a month, or about $75 a month on a yearly plan. The first month is $39. It covers visits, insurance checks and follow-up.
• The medicine. Billed separately. Paying cash, you pay Lilly's self-pay price, about $300 to $450 a month. With coverage, you pay your plan's copay.

Paying cash, that's about $450 to $600 a month all-in. The membership sits on top of the drug price. It doesn't lower it. Ask for both numbers before you enroll. Our LifeMD cost breakdown has the details.

Is compounded Zepbound cheaper, and is it actually Zepbound?

It isn't Zepbound. Zepbound is Lilly's FDA-approved finished drug. "Compounded tirzepatide" is the same active ingredient mixed by a licensed pharmacy for one patient. It hasn't gone through the FDA's finished-drug review.

Its legal footing shrank in 2025. The FDA declared the tirzepatide shortage over in December 2024. That ended the wave of mass-made cheap versions. A pharmacy can still compound tirzepatide for one patient when a clinician documents a medical reason. Cost alone doesn't count under FDA rules.

On April 30, 2026, the FDA also proposed not to add tirzepatide to the 503B bulk drug list. That list governs large outsourcing facilities, not the pharmacies that fill one patient's prescription. The comment period closed July 30, 2026. No final decision has been published.

Month to month, compounded tirzepatide runs about $130 to $650 a month, depending on the seller and the dose. Some prepaid plans start lower. See compounded tirzepatide providers compared for every seller, or Zepbound vs. tirzepatide for the brand-versus-compounded choice.

Mounjaro vs. Zepbound: is one cheaper than the other?

Both are tirzepatide, sold under two FDA approvals. Mounjaro is approved for type 2 diabetes. Zepbound is approved for weight management and sleep apnea with obesity. That split is why their prices differ.

• Mounjaro. List price about $1,110 a month at every dose. Lilly sells it to cash payers for about $500 a month at every dose. Its savings card has a $25 tier if your work plan covers it.
• Zepbound. List price about $1,085. Lilly's self-pay price is lower, about $300 to $450 by dose.

If your prescription is for weight management, you're working inside Zepbound's prices and coverage rules. A Mounjaro coupon won't apply to a Zepbound prescription, and the reverse is also true. See Mounjaro cost for its full breakdown.

What if you skip every program? Retail and GoodRx prices

A GoodRx coupon at a retail pharmacy brings Zepbound to about $995 to $1,050 a month, depending on the pharmacy. That's barely below list price. GoodRx may also show Lilly's own self-pay KwikPen price. That lower figure is Lilly's program, not a coupon discount.

The list price, with no program at all, is about $1,085 a month at every dose. Before you pay that, check Lilly's self-pay price, your savings card, Medicare's Bridge, or a compounded option.

What a year of Zepbound costs on each path

Zepbound comes in 28-day boxes, so a year means 13 fills. The yearly totals below follow the label's dose steps: 2.5 mg for 4 weeks, then 5 mg, then higher if your clinician raises it.

• Insured, savings card, covered: about $325 a year at $25 a fill, if your copay stays within the card's limits.
• Medicare GLP-1 Bridge: about $650 a year at $50 a month.
• Lilly self-pay, staying at 5 mg after the first month: about $5,100 in the first year.
• Lilly self-pay, moving up to 7.5 mg or higher: about $5,650 in the first year, if every fill gets the self-pay price.
• List price, no program: about $14,100 a year.

Two rules can push the higher-dose total up. Lilly's KwikPen self-pay terms cover up to 11 fills in a calendar year. A full year of 28-day boxes takes 13. The higher-dose price also needs each refill within 45 days. Outside those rules, a 7.5 mg fill costs about $500. From 10 mg, it costs about $700.

These totals use Lilly's current prices. Its self-pay and savings card terms end December 31, 2026.

The gap between the best insured year and an uncovered retail year runs past $13,000. That's why it pays to check your coverage and the savings card before your very first fill.

How to choose, and the red flags to watch for

A few patterns are hard stops on any path. A seller offering tirzepatide or Zepbound without a prescription or a clinician visit isn't operating legally. That's a real risk of fakes and dosing errors.

A cash price for brand-name Zepbound well below Lilly's own self-pay price, about $300 a month, is another warning sign. A compounded seller should tell you which licensed pharmacy fills your prescription and whether it's accredited. It should also explain how your medical need is documented.

• Lilly self-pay fits you if you want the FDA-approved brand without insurance and can refill within 45 days.
• The savings card fits you if you have commercial insurance. Check both the covered and not-covered prices.
• The Medicare Bridge fits you if you have Part D and meet its BMI and health rules.
• Compounded tirzepatide fits you if cash price decides it and you've read the compounded seller comparison, not just the first ad you saw.
• Walk away if a seller skips the prescription step, or a compounded seller can't name its pharmacy.